Dr. Darya Blednova, MD

Dr. Blednova practices at CHI Health Good Samaritan - Unit in Kearney, Nebraska.

Dr. Blednova's NPI, 1023451010, was assigned on April 10, 2013. Dr. Blednova holds Oregon license MD214121.

Dr. Blednova's primary practice is CHI Health Good Samaritan - Unit, at 10 E 31st Street, Kearney, NE 68848 in Buffalo County. The practice phone is (308) 865-7189.

Dr. Blednova's primary practice is CHI Health Good Samaritan - Unit in Kearney, Nebraska. Dr. Blednova is also affiliated with CHI Health Good Samaritan. The medical group on file is CHI Health Clinic. Dmand AI also links Dr. Blednova to 2 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blednova practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Blednova's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Blednova is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Blednova's licenses on file in 2 states: Oregon and New York.

CMS data shows 297 Medicare services from Dr. Blednova across 2 procedure codes in 2024, for 33 Medicare patients. Medicare paid $17,571 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Blednova in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have copd, and 75% have high blood pressure. 36% are also on Medicaid. Their average risk score is 4.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blednova's median patient age at 66, with 54% women.

In 2024, Dr. Blednova wrote 46 Medicare Part D claims for 19 patients. 87% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $436 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

Dr. Blednova accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Dr. Blednova from 6 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $132.